CLINICAL TRIALS PROFILE FOR UNISOM

All Clinical Trials for UNISOM

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00226941 ↗	A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer	Terminated	Bristol-Myers Squibb	Phase 1/Phase 2	2004-06-01	The objectives of this study are to: 1. To assess dose-limiting toxicities (DLTs) of capecitabine +/- oxaliplatin in a combination regimen with capecitabine and radiotherapy (Phase 1) 2. To determine the maximum-tolerated dose (MTD) when capecitabine - oxaliplatin in a combination regimen with capecitabine and radiotherapy (Phase 1) 3. To determine the pathologic response rate of cetuximab +/- oxaliplatin in combination with capecitabine and radiotherapy (Phase 2)
NCT00226941 ↗	A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer	Terminated	George Albert Fisher	Phase 1/Phase 2	2004-06-01	The objectives of this study are to: 1. To assess dose-limiting toxicities (DLTs) of capecitabine +/- oxaliplatin in a combination regimen with capecitabine and radiotherapy (Phase 1) 2. To determine the maximum-tolerated dose (MTD) when capecitabine - oxaliplatin in a combination regimen with capecitabine and radiotherapy (Phase 1) 3. To determine the pathologic response rate of cetuximab +/- oxaliplatin in combination with capecitabine and radiotherapy (Phase 2)
NCT01158820 ↗	Alternative Sedation During Bronchoscopy	Completed	Hospira, Inc.	Phase 4	2010-06-01	This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01158820 ↗	Alternative Sedation During Bronchoscopy	Completed	Hospira, now a wholly owned subsidiary of Pfizer	Phase 4	2010-06-01	This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01158820 ↗	Alternative Sedation During Bronchoscopy	Completed	University of Pennsylvania	Phase 4	2010-06-01	This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.

Clinical Trial Conditions for UNISOM

Condition Name

Condition Name for UNISOM
Intervention	Trials
Colo-rectal Cancer	1
Colon/Rectal Cancer	1
Colon/Rectal Cancer Rectal Cancer	1
Rectal Cancer	1

Condition MeSH

Condition MeSH for UNISOM
Intervention	Trials
Rectal Neoplasms	1
Colorectal Neoplasms	1

Clinical Trial Locations for UNISOM

Trials by Country

Trials by Country for UNISOM
Location	Trials
United States	2

Trials by US State

Trials by US State for UNISOM
Location	Trials
Pennsylvania	1
California	1

Clinical Trial Progress for UNISOM

Clinical Trial Phase

Clinical Trial Phase for UNISOM
Clinical Trial Phase	Trials
Phase 4	1
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for UNISOM
Clinical Trial Phase	Trials
Completed	1
Terminated	1

Clinical Trial Sponsors for UNISOM

Sponsor Name

Sponsor Name for UNISOM
Sponsor	Trials
Bristol-Myers Squibb	1
George Albert Fisher	1
Hospira, Inc.	1

Sponsor Type

Sponsor Type for UNISOM
Sponsor	Trials
Industry	3
Other	2